Ad5/3-E2F-d24-GMCSF

AXP000067.1 · Oncolytic virus

Platform
adenovirus (Ad5/3 chimera, E2F-1 promoter, Delta-24, GM-CSF-armed)
Originator
University of Helsinki (Akseli Hemminki)

Names

NameTypeSource
Ad5/3-E2F-d24-GMCSFpreferred name, codecurator, paper

Virus

Role
Oncolytic
Family
Adenoviridae
Virus
human adenovirus 5 (NCBI Taxonomy 28285)
Strain
Ad5/3 chimera
Replication
conditionally replicating
Modifications
E2F-1 promoter drives E1A; Delta-24; Ad3 fiber knob
Transgenes
CSF2
Route
intratumoral, intraperitoneal, intrapleural, intravenous
Source
evidence

Approvals

No regulatory approval recorded.

Clinical trials (0)

No trial in the latest ClinicalTrials.gov snapshot names this program.

Recent changes

No changes recorded in its trials yet.

Notes

ATAP construct (2007-2012). Sometimes given the code CGTG-602; the code was not verified here, so it is not listed as an alias.

How to cite

Ad5/3-E2F-d24-GMCSF (AXP000067.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000067.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.